Aandeel BNKL BIONIK LABORATORIES CORP.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Bionik Laboratories Corp.

Aandelen

BNKL

US09074A2087

Beurs gesloten - OTC Markets
Andere beurzen
 02:10:00 30-11-2023 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
0,000001 USD -.--% Intraday-grafiek van Bionik Laboratories Corp. -.--% -.--%
2023 Bionik Laboratories Corp. Kondigt wijzigingen in het management aan CI
2023 Bionik Laboratories Corp. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 maart 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Bionik Laboratories Corp. Announces Executive Changes
Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023
Bionik Laboratories Corp. Auditor Raises 'Going Concern' Doubt
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
Bionik Laboratories Expands Its Partnership with Lifepoint Health with the Installation of InMotion Robotic Devices at Four New Locations
Bionik Laboratories : Private Placement - Form 8-K
Bionik Laboratories Corp. Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations
Bionik Laboratories Corp. announced that it expects to receive $2 million in funding
Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Bionik Laboratories Corp. announced that it has received $0.25 million in funding
Bionik Laboratories InMotion Robotic Devices on Display at the Korea International Medical and Hospital Equipment Show
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Bionik Laboratories Corp. announced that it has received $0.5 million in funding
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
BIONIK LABORATORIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Bionik Laboratories Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Earnings Flash (BNKL) BIONIK LABORATORIES Posts Q3 Revenue $575.1M
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers BNKL
  4. Nieuws Bionik Laboratories Corp.
  5. Andere talen